Table: Sapporo Clinical Lab -2017/18 parent results

Sapporo Clinical Laboratory

11/05/2018 07:30

May 11 (Reuters)- 
          Sapporo Clinical Laboratory Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           16.39           15.87          16.72         8.34    
               (+3.3 pct)      (-2.5 pct)     (+2.0 pct)    (+1.6 pct) 
  Operating      963 mln         734 mln                               
               (+31.3 pct)     (-21.3 pct)                             
  Recurring      998 mln         764 mln          1.00       460 mln   
               (+30.6 pct)     (-20.4 pct)    (+0.2 pct)    (-7.8 pct) 
  Net            649 mln         488 mln        681 mln      312 mln   
               (+33.0 pct)     (-14.3 pct)    (+4.9 pct)    (-6.0 pct) 
  EPS          186.80 yen      140.39 yen     196.79 yen    90.38 yen  
  Ann Div       11.00 yen       10.00 yen      10.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       11.00 yen       10.00 yen      10.00 yen               
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T